Literature DB >> 23060188

A call for transparent reporting to optimize the predictive value of preclinical research.

Story C Landis1, Susan G Amara, Khusru Asadullah, Chris P Austin, Robi Blumenstein, Eileen W Bradley, Ronald G Crystal, Robert B Darnell, Robert J Ferrante, Howard Fillit, Robert Finkelstein, Marc Fisher, Howard E Gendelman, Robert M Golub, John L Goudreau, Robert A Gross, Amelie K Gubitz, Sharon E Hesterlee, David W Howells, John Huguenard, Katrina Kelner, Walter Koroshetz, Dimitri Krainc, Stanley E Lazic, Michael S Levine, Malcolm R Macleod, John M McCall, Richard T Moxley, Kalyani Narasimhan, Linda J Noble, Steve Perrin, John D Porter, Oswald Steward, Ellis Unger, Ursula Utz, Shai D Silberberg.   

Abstract

The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and publications. The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data. We recognize that achieving a meaningful improvement in the quality of reporting will require a concerted effort by investigators, reviewers, funding agencies and journal editors. Requiring better reporting of animal studies will raise awareness of the importance of rigorous study design to accelerate scientific progress.

Entities:  

Mesh:

Year:  2012        PMID: 23060188      PMCID: PMC3511845          DOI: 10.1038/nature11556

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  60 in total

1.  Guidelines for the design and statistical analysis of experiments using laboratory animals.

Authors:  Michael F W Festing; Douglas G Altman
Journal:  ILAR J       Date:  2002

2.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

Review 3.  Pharmacokinetic/ pharmacodynamic-driven drug development.

Authors:  James M Gallo
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug

4.  "Positive" results increase down the Hierarchy of the Sciences.

Authors:  Daniele Fanelli
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 5.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

6.  Design, power, and interpretation of studies in the standard murine model of ALS.

Authors:  Sean Scott; Janice E Kranz; Jeff Cole; John M Lincecum; Kenneth Thompson; Nancy Kelly; Alan Bostrom; Jill Theodoss; Bashar M Al-Nakhala; Fernando G Vieira; Jeyanthi Ramasubbu; James A Heywood
Journal:  Amyotroph Lateral Scler       Date:  2008

7.  Bias in treatment assignment in controlled clinical trials.

Authors:  T C Chalmers; P Celano; H S Sacks; H Smith
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

8.  Pooling of animal experimental data reveals influence of study design and publication bias.

Authors:  Malcolm R Macleod; Tori O'Collins; David W Howells; Geoffrey A Donnan
Journal:  Stroke       Date:  2004-04-01       Impact factor: 7.914

9.  Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies.

Authors:  Diana W Shineman; Guriqbal S Basi; Jennifer L Bizon; Carol A Colton; Barry D Greenberg; Beth A Hollister; John Lincecum; Gabrielle G Leblanc; Linda Bobbi H Lee; Feng Luo; Dave Morgan; Iva Morse; Lorenzo M Refolo; David R Riddell; Kimberly Scearce-Levie; Patrick Sweeney; Juha Yrjänheikki; Howard M Fillit
Journal:  Alzheimers Res Ther       Date:  2011-09-28       Impact factor: 6.982

10.  A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials.

Authors:  Stephanie L Prady; Stewart J Richmond; Veronica M Morton; Hugh Macpherson
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

View more
  509 in total

Review 1.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

2.  PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis.

Authors:  Audrey S Dickey; Dafne N Sanchez; Martin Arreola; Kunal R Sampat; Weiwei Fan; Nicolas Arbez; Sergey Akimov; Michael J Van Kanegan; Kohta Ohnishi; Stephen K Gilmore-Hall; April L Flores; Janice M Nguyen; Nicole Lomas; Cynthia L Hsu; Donald C Lo; Christopher A Ross; Eliezer Masliah; Ronald M Evans; Albert R La Spada
Journal:  Sci Transl Med       Date:  2017-12-06       Impact factor: 17.956

3.  Informatics tools to assess the success of procedural harmonization in preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.

Authors:  Robert Ciszek; Xavier Ekolle Ndode-Ekane; Cesar Santana Gomez; Pablo M Casillas-Espinosa; Idrish Ali; Gregory Smith; Noora Puhakka; Niina Lapinlampi; Pedro Andrade; Alaa Kamnaksh; Riikka Immonen; Tomi Paananen; Matthew R Hudson; Rhys D Brady; Sandy R Shultz; Terence J O'Brien; Richard J Staba; Jussi Tohka; Asla Pitkänen
Journal:  Epilepsy Res       Date:  2018-12-27       Impact factor: 3.045

4.  Post-Translational Tubulin Modifications in Human Astrocyte Cultures.

Authors:  V Bleu Knight; Elba E Serrano
Journal:  Neurochem Res       Date:  2017-05-17       Impact factor: 3.996

Review 5.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

6.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

Review 7.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

8.  Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.

Authors:  Jeremy S Francis; Vladimir Markov; Paola Leone
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

9.  Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools.

Authors:  Shawn Minnig; Robert M Bragg; Hardeep S Tiwana; Wes T Solem; William S Hovander; Eva-Mari S Vik; Madeline Hamilton; Samuel R W Legg; Dominic D Shuttleworth; Sydney R Coffey; Jeffrey P Cantle; Jeffrey B Carroll
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

Review 10.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.